Retinoblastoma: one world, one vision

Pediatrics. 2008 Sep;122(3):e763-70. doi: 10.1542/peds.2008-0518.


Retinoblastoma is curable when diagnosed early and treated appropriately; however, the prognosis is dismal when the basic elements of diagnosis and treatment are lacking. In developing countries, poor education, lower socioeconomic conditions, and inefficient health care systems result in delayed diagnosis and suboptimal care. Furthermore, the complexity of multidisciplinary care required is seldom possible. Whereas ocular salvage is a priority in the Western world, death from retinoblastoma is still a major problem in developing countries. To bring the 2 ends of this spectrum together and provide a forum for discussion, the "One World, One Vision" symposium was organized, at which clinicians and researchers from various cultural, geographic, and socioeconomic backgrounds converged to discuss their experiences. Strategies for early diagnosis in developing countries were discussed. Elements of the development of retinoblastoma centers in developing countries were discussed, and examples of successful programs were highlighted. An important component in this process is twinning between centers in developing countries and mentor institutions in high-income countries. Global initiatives by nongovernmental organizations such as the International Network for Cancer Treatment and Research, Orbis International, and the International Agency for Prevention of Blindness were presented. Treatment of retinoblastoma in developing countries remains a challenge; however, it is possible to coordinate efforts at multiple levels, including public administrations and nonprofit organizations, to improve the diagnosis and treatment of retinoblastoma and to improve the outcome for these children.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Child
  • Combined Modality Therapy / methods
  • Developing Countries
  • Diagnosis, Differential
  • Humans
  • Prevalence
  • Prognosis
  • Quality Assurance, Health Care*
  • Retinal Neoplasms* / diagnosis
  • Retinal Neoplasms* / epidemiology
  • Retinal Neoplasms* / therapy
  • Retinoblastoma* / diagnosis
  • Retinoblastoma* / epidemiology
  • Retinoblastoma* / therapy
  • Risk Factors
  • Socioeconomic Factors
  • Survival Rate